GlassScriptPhysician profile
Misty M Moy
NPI 1649689654
$1,697.35
in general payments reported to CMS, 2019-2025
16 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $180 · 2023: $468 · 2024: $494 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $336.00 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Nevro Corp. | $205.37 | 2021-2024 | Senza |
| Inspire Medical Systems, INC. | $179.26 | 2025 | Inspire |
| Abbvie INC. | $124.40 | 2024 | |
| Idorsia Pharmaceuticals US INC | $124.04 | 2023 | Quviviq |
| Dexcom, INC. | $116.71 | 2023 | Dexcom G7 Gss (161) |
| Corcept Therapeutics | $114.93 | 2024 | Korlym |
| Melinta Therapeutics, LLC | $107.45 | 2023 | Kimyrsa |
| Kerecis Limited | $105.44 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bayer Healthcare Pharmaceuticals INC. | $100.41 | 2024 | |
| Cardiovascular Systems INC. | $53.77 | 2022 | |
| Stryker Corporation | $47.72 | 2024 | Spy-Phi System |
| W. L. Gore & Associates, INC. | $29.37 | 2025 | Gore Synecor Biomaterial |
| Applied Medical Technology INC | $18.29 | 2024 | |
| Kci USA, INC. | $17.30 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.89 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Moy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.